7 6 0 VOLUME 21 | NUMBER 7 | JULY 2015 nAture medicine Obesity, mainly characterized by increased adiposity, has reached pandemic proportions and is a major contributor to metabolic disorders. In mammals, there are two functionally distinct types of fat: white adipose tissue (WAT), which is specialized for energy storage, and BAT, which dissipates energy for thermogenesis 1,2 via the activity of UCP1. In addition to the classical brown adipocytes, UCP1-positive 'beige' or 'brite' adipocytes can be recruited within WAT upon chronic cold or β3-adrenergic stimulation [3][4][5][6] . Because of the immense capacity of BAT to combust fuels for heat production 7,8 and owing to its presence in adult humans 9-14 , increasing the amount or activity of brown or beige fat has been considered an appealing approach for the treatment or prevention of obesity and related metabolic disorders. Indeed, in rodents the activation of brown or beige fat can increase energy expenditure and is protective against diet-induced obesity 5,6, 15 . In humans, BAT mass or activity is inversely correlated to body mass index and percentage of body fat [10] [11] [12] , and cold exposure can elevate BAT volume and activity and increase energy expenditure, thus pointing toward the therapeutic potential of BAT in humans for the treatment of obesity and metabolic disease [16] [17] [18] .
Obesity, mainly characterized by increased adiposity, has reached pandemic proportions and is a major contributor to metabolic disorders. In mammals, there are two functionally distinct types of fat: white adipose tissue (WAT), which is specialized for energy storage, and BAT, which dissipates energy for thermogenesis 1,2 via the activity of UCP1. In addition to the classical brown adipocytes, UCP1-positive 'beige' or 'brite' adipocytes can be recruited within WAT upon chronic cold or β3-adrenergic stimulation [3] [4] [5] [6] .
Because of the immense capacity of BAT to combust fuels for heat production 7, 8 and owing to its presence in adult humans [9] [10] [11] [12] [13] [14] , increasing the amount or activity of brown or beige fat has been considered an appealing approach for the treatment or prevention of obesity and related metabolic disorders. Indeed, in rodents the activation of brown or beige fat can increase energy expenditure and is protective against diet-induced obesity 5, 6, 15 . In humans, BAT mass or activity is inversely correlated to body mass index and percentage of body fat [10] [11] [12] , and cold exposure can elevate BAT volume and activity and increase energy expenditure, thus pointing toward the therapeutic potential of BAT in humans for the treatment of obesity and metabolic disease [16] [17] [18] .
Recent data indicate that the neck, supraclavicular and spinal cord regions of adult humans contain substantial deposits of UCP1-positive adipocytes [19] [20] [21] [22] . The presence of brown, beige, and white adipocytes, and possibly other unidentified adipose cell types, highlights the heterogeneity of adipose tissue depots, which is potentially related to their diverse functions in energy metabolism. Both inter-subject differences and various cellular compositions within a given fat tissue contribute to the heterogeneity of human BAT and affect thermogenic potential. In rodents, lineage tracing and cell sorting analyses have demonstrated that the various types of fat cells arise from discrete pools of progenitors, which express distinct molecular markers 19, [23] [24] [25] [26] . However, whether the markers identified in mouse cells can unambiguously define different types of human adipose progenitors is currently unknown.
A key impediment for these studies is the lack of human-derived brown and white fat progenitor cell models. To investigate the heterogeneous nature of the progenitor cell population in human BAT and WAT, we generated clonal cell lines from human neck fat and characterized their adipogenic differentiation and metabolic function in vitro and in vivo after transplantation into immune-deficient nude mice. Using clonal analysis and gene-expression profiling, we defined unique sets of gene signatures in human preadipocytes that could predict the thermogenic potential of these cells once they have matured in culture into adipocytes. These data highlight the cellular heterogeneity in human BAT and WAT and provide novel gene markers that may be targeted or selected to prime preadipocytes for strong thermogenic differentiation.
RESULTS

Generation and characterization of human fat progenitors
We previously reported that adult human BAT and WAT are present in defined neck locations 20 , and we found that deeper human neck fat is predominantly brown, as these depots express substantially higher levels of the brown fat-specific marker UCP1 compared to the depots of superficial neck fat. To define molecular and functional characteristics of specific adipose progenitors, we generated human preadipocyte cell populations derived from a total of four human subjects by isolating cells from the stromal vascular fraction (SVF) of human neck fat and immortalizing them via stable expression of human telomere reverse transcriptase (hTERT) 27 ( Supplementary  Fig. 1a) . Pairs of immortalized progenitors for human BAT Data are presented as fold changes relative to subject1-derived hWAs (n = 3 per group, biological replicates). (e) Oxygen consumption rate (OCR) was measured in the absence (basal respiration, Basal res.) or presence of oligomycin (Proton leak) or FCCP (maximal respiration, Max. res.) in hWAs and hBAs from Sub1 (left) and Sub2 (right). Data are presented as mean ± s.e.m. (n = 10 per group, biological replicates; hWAs versus hBAs). (f) Glucose uptake was measured using [ 3 H]2-deoxy-glucose in hWAs and hBAs stimulated with (Ins100) or without (Ins0) 100 nM insulin from Sub1 (left) and Sub2 (right) (n = 3 per group, biological replicates). (g) Fatty acid uptake (FAU) and fatty acid oxidation (FAO) were measured using [ 14 C]palmitic acid in hWAs and hBAs from Sub1 (left) and Sub2 (right). Data are presented as fold change compared to FAU or FAO from hWAs (n = 3 per group, biological replicates). AU, arbitrary unit. (h) qRT-PCR analysis for UCP1 and PPARG mRNA expression in hWAs and hBAs from Sub1 (left) and Sub2 (right). Data are presented as fold changes compared to mRNA expression in vehicle-treated (veh) hWAs for each subject (n = 3 per group, biological replicates; NS, not significant; Veh versus BMP7). Throughout, error bars represent mean ± s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001 by two-tailed Student's t-test. A representative experiment from a total of three independent studies is shown.
(hBAT-SVF cells, isolated from deep neck fat) and human WAT (hWAT-SVF cells, isolated from superficial neck fat) of the same individuals were established from each of the four individuals for proper comparisons (Supplementary Table 1a) . The immortalized cells were passaged in culture for more than 90 d and were followed for up to 20 population doublings (Supplementary Fig. 1b) .
After immortalization, the cells from both WAT and BAT depots of the four human subjects maintained a fibroblast-like morphology, and after induction with a standard adipogenic differentiation protocol most of the precursors became lipid-laden cells that highly expressed the mature adipocyte marker fatty acid synthase (FASN) (Fig. 1a and Supplementary Fig. 1c) . Notably, in differentiated hBAT-SVF cells (referred to as human brown adipocytes, hBAs), expression of the brown fat marker UCP1 was up to 200-fold higher than in differentiated hWAT-SVF cells (human white adipocytes, hWAs) (Fig. 1b) , and was accompanied by robust induction of UCP1 protein ( Fig. 1c and Supplementary Fig. 1d) . A comparable pattern of expression was observed for other brown fat markers, such as deiodinase 2 (DIO2) and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) (Supplementary Fig. 1c) . LEP (which encodes for leptin), a marker of WAT, was selectively expressed in hWAs compared to hBAs in all subjects (Fig. 1d) . Importantly, the immortalized cells retained differentiation characteristics of primary cells (Supplementary Fig. 2 ).
To determine whether the differentiated cells possessed metabolic capacity, we evaluated cellular respiration and fuel utilization in hBAs and hWAs from two subjects (referred to herein as subjects 1 and 2). Consistent with differences in gene expression, the levels of basal and maximal respiration, as well as proton leak, in hBAs were higher compared to those in hWAs (Fig. 1e) . Glucose uptake in both the basal and insulin-stimulated states was also notably higher in hBAs than in hWAs, as were both fatty acid uptake and oxidation rate (Fig. 1f,g ). Differentiated brown, but not white, adipocytes were able to respond to forskolin, a chemical mimic of β-adrenergic stimulation, by increasing the oxygen consumption rate ( Supplementary  Fig. 3a) . In addition, hBAs from subject 2 could respond to stimulations by norepinephrine and other browning agents by increasing the levels of UCP1 and DIO2 (Supplementary Figs. 3b and 4) , suggesting that the mature human brown adipocytes are responsive to both physiological and pharmacological adrenergic stimuli.
Recent studies using mouse systems have demonstrated that adipose progenitors can respond to inductive signals and increase their thermogenic capacity in mature adipocytes 4, 23, 28 . To determine whether human-derived progenitors can respond to browning agents, we pretreated the aforementioned precursors from subjects 1 and 2 with bone morphogenetic protein 7 (BMP7) 23,29 for 6 d, followed by adipogenic induction. Pre-exposure to BMP7 of hWAT-SVF cells from both subjects and hBAT-SVF cells from subject 2 led to increased UCP1 expression, mitochondrial activity and fuel utilization in mature adipocytes ( Fig. 1h and Supplementary Fig. 5a-f ), suggesting that a fraction of these progenitors are inducible. Pretreatment with BMP7 also augmented peroxisome proliferator-activated receptor gamma (PPARG) expression in brown adipocytes from subject 2 only. BMP8, another browning agent 28 , exerted similar effects (Supplementary Fig. 5a ).
The fact that hBAT-SVF cells and hBAs derived from subject 2, but not subject 1, consistently responded to browning agents suggested that the cells derived from subject 2 are more inducible, whereas cells derived from subject 1 may represent the classical brown fat cells, which possess a very high basal level of UCP1. The distinction of classical versus inducible hBAs between subjects 1 and 2 was further supported by the differential expression levels of the classical BAT marker ZIC1 (refs. 4,30,31) (Supplementary Fig. 5g ).
These data support the previous characterization of the tissue from human neck BAT and WAT 20 and demonstrate that the progenitor cell populations we have generated recapitulate adipogenic differentiation and thermogenic expression profiles in vitro. Further, inter-subject differences not only exist in whole adipose tissue as previously noted 20 , but also exist in adipose progenitors and their derived adipocytes in culture. Despite the inter-subject variations, human brown adipocytes clearly possess high levels of UCP1 and great bioenergetic capacity.
Reporter system for monitoring UCP1 expression To allow direct assessment of the thermogenic potential of differentiated cells, we introduced a transgenic reporter construct into the white and brown fat precursors to measure UCP1 gene expression by coupling a bicistronic luciferase and green fluorescent protein (GFP) reporter system to a 4.1-kb human UCP1 promoter fragment (Fig. 2a) . In mature adipocytes that stably expressed the reporter construct, luciferase activity was strongly correlated with endogenous UCP1 gene expression and only detected in mature brown adipocytes, but not in undifferentiated cells (Fig. 2b) . We monitored differentiating cells using time-lapse microscopy and could detect activation of the GFP reporter as early as day 9 in differentiating BAT cells ( and Supplementary Video). To determine if these cells were capable of differentiation in vivo, we transplanted progenitor cells into immune-deficient nude mice and used in vivo bioluminescence imaging to measure UCP1 reporter activity. Luciferase activity was high in mice implanted with hBAT progenitors, and it could be further induced by BMP7 pretreatment of progenitors ( Fig. 2d) . Conversely, mice receiving transplanted hWAT progenitors displayed almost no detectable luciferase activity. Although both grafts expressed similar levels of FABP4, fat grafts with hBAT-SVF cells displayed at least a 100-fold increase in UCP1 mRNA compared to hWAT-SVF-derived fat pads, which is consistent with the observed luciferase activity. LEP was selectively expressed in fat grafts from hWAT-SVF cells (Fig. 2e ). These data demonstrate that the UCP1 reporter system accurately indicates differentiation into mature brown adipocytes in both in vivo and in vitro settings.
Clonal analysis of human brown and white fat progenitors
To study homogenous cell populations derived from human adipose precursor cells, we isolated a total of 280 clonal preadipocyte cell lines (152 hWAT-SVF clones and 128 hBAT-SVF clones) from the pooled immortalized preadipocyte populations from all four subjects. Of these lines, 44% (67 out of 152) of hWAT-SVF and 70% -(90 out of 128) of hBAT-SVF clones robustly differentiated into mature adipocytes ( Fig. 3 and Supplementary Fig. 6 ). To determine UCP1 induction in the differentiated state, we measured luciferase reporter activity in each clonal line after 18 d of adipogenic differentiation ( Supplementary Fig. 7) . Notably, the data revealed that up to 96% of the hWAT-SVF clones were UCP1 negative, whereas more than 94% of the hBAT-SVF clones displayed different levels of UCP1-luciferase activity (Fig. 3) .
As shown in Figure 1h , certain subpopulations of hWAT or hBAT precursors could respond to inductive signals, such as BMP7, to further increase their thermogenic capacity. To identify the precursor clones that could respond to stimulation, we pretreated undifferentiated cells with BMP7 and determined reporter expression in mature cells. Although only 1% of the highly adipogenic hWAT-SVF clones could respond to BMP7 pretreatment, a substantial number of hBAT-SVF clones (up to 37%) could be induced by BMP7 pretreatment (Fig. 3) . Further analysis of the clones in terms of their human-subject origins revealed that more than 60% of the hBAT-SVF clones from subjects 2 and 3 could respond to BMP7 stimulation while the majority of the hBAT-SVF clones from subjects 1 and 4 were not responsive to BMP7 pretreatment (Supplementary Table 2 ). These data not only supported the analysis of the pooled progenitor populations described above, but also suggested that the thermogenic features of mature adipocytes are regulated by the anatomical location of the tissue they originate from in addition to genetic influences of the individual human subjects. They also highlighted the heterogeneity of the human adipose clones, even among cell lines isolated from the same subject and a common tissue.
Gene signatures predict thermogenic potential of adipocytes
We aimed to identify molecular markers of thermogenically competent cells. To this end, we took advantage of the UCP1 reporter system for each clonal cell line to select a set of clones from all four subjects, which represented a wide range of luciferase activities after adipogenic differentiation, for further analysis (Fig. 4a) . We assayed these clones' gene expression profiles in the preadipocyte state using microarrays and correlated these with UCP1 expression in the differentiated state. After applying the stringent threshold of P < 0.001, which is associated with a false discovery rate (FDR) of 0.03, we prioritized 581 genes that displayed significant positive correlation and 454 genes that displayed significant negative correlation (Fig. 4b) . A subset of these genes is shown along with UCP1 in Figure 4c , illustrating the association between gene expression in the preadipocyte state and UCP1 expression in the differentiated state. Interestingly, several previously identified brown and white fat markers are among the list of positive or negative predictors (Supplementary Table 3) .
Scatter plot analysis revealed two general categories of genes in preadipocytes that may regulate induction of a thermogenic program during late stages of differentiation (Fig. 4d) . The first category of genes could act as binary 'on-and-off ' switches to determine cell fate. Positive regulators in this category are likely to be required for thermogenic differentiation, whereas negative regulators would be completely suppressed to allow the UCP1 gene to be expressed. Representatives of this category included phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 (PREX1) 32 , cortactin binding protein 2 (CTTNBP2) 33 , cardiac actin 1(ACTC1) 34 and somatostatin receptor 1 (SSTR1) 35 . The second category of genes could act as genetic rheostats to suppress or enhance thermogenic capacity incrementally as their expression levels change. Positive regulators in this category, such as doublesex and mab-3-related transcription factor-like family A1 (DMRTA1) 36 and endothelin receptor type B (EDNRB) 37 , might support thermogenic differentiation in proportion to their expression levels. Negative regulators-such as FAT atypical cadherin 1 (FAT1) 38 and protein tyrosine phosphatase, receptor type, Figure 3 Clonal analysis of human brown and white fat progenitors. The clonal analysis strategy of hWAT-SVF and hBAT-SVF cell progenitors is shown as a dendrogram. 152 clones from hWAT-SVF cells and 128 clones from hBAT-SVF cells were derived by limiting dilution of pooled cells from four subjects. Adipogenic capacity was determined by Nile red staining and UCP1 levels were determined by luciferase activity on day 18. Detailed selection criteria are described in Supplementary  Figures 6 and 7 . Selected highly adipogenic clones (adipogenic ++ ) were pretreated with 3.3 nM BMP7 for 6 d and then differentiated into mature adipocytes in a 96-well plate. Luciferase activity was measured on day 18 and the cells were divided into different groups on the basis of the level (negative, neg; low; medium, med; and high) of normalized (to protein content) luciferase activity. The positive response (resp. (+)) to BMP7 pretreatment was defined as >1.5-fold increase of luciferase activity in BMP7-pretreated versus vehicle groups. 39 -might further suppress thermogenic potential when they are more highly expressed. Notably, most of these candidate genes have never been directly implicated in adipocyte differentiation or thermogenic regulation.
Essential roles of PREX1 and EDNRB in thermogenic competency
To select promising candidate genes for further analyses, we applied the following three criteria to the above analysis. First, the primary selection criterion was based on their correlation coefficients, CDH13   TEK   EPB41L3  KRTCAP2  NUCB2  SMYD2  PSME4  TJPI   GRIK2   ZNF518B   ANTXR1  SLC7A6  FAT1  THBS1  TOM1L1  CSRP2  STXBP6  ACTC1  SHROOM3  WNT2  HAPLN1  COL12A1 npg P values and FDR values (Fig. 4c and Supplementary Table 4) . Second, the top-ranking candidate genes were further verified by qRT-PCR assays in a set of ten independent single-cell clones derived from the same four subjects (but not included in the original microarray analysis) for positive or negative correlations between the expression levels of the selected candidate genes in the preadipocytes and UCP1 mRNA levels in mature adipocytes (Fig. 5a) . Third, they were also validated in seven pairs of the human neck BAT and WAT (Supplementary Fig. 8 ).
To validate the roles of some of these identified biomarkers in thermogenic capacity, we used CRISPR-Cas9 to knock out the positive UCP1 regulators PREX1 and EDNRB in an hBAT-SVF clone (Fig. 5b) . Compared to control cells, gene ablation had no effect on the differentiation of precursor cells into lipid-laden adipocytes that expressed normal levels of PPARG (Fig. 5c,d) . Expression of the thermogenic markers UCP1, DIO2 and PPARGC1A, however, were markedly decreased in both knockout cell lines (Fig. 5d) . Consequently, basal respiration, proton leak, and maximal respiration capacity were significantly reduced in PREX1-knockout cells compared to control cells (P = 0.03835, 0.02884, and 0.00932, respectively) ( Supplementary  Fig. 9a-c) . Similarly, EDNRB-knockout cells showed a significant reduction of maximal respiration (P = 0.03351) and a trend of lower levels of basal respiration and proton leak compared to control cells. To test the effects of a negative regulator on UCP1 expression, we knocked out SSTR1 in an hWAT-SVF clone (Fig. 5e) . As we observed for the positive regulators, gene deletion had no effect on adipogenic differentiation, yet thermogenic gene expression remained repressed in white adipocytes (Fig. 5f,g ). These data demonstrated the predictive value of the genes that we identified with our microarray analysis and suggested that the gene expression network that positively regulates thermogenic competency may be more sensitive to perturbation when there is at least some redundancy in the negative regulatory network of genes.
Isolation of thermogenically competent progenitors by CD29
To identify surface markers that could be used to isolate precursors with thermogenic competency, we focused on genes encoding cell surface proteins that had expression patterns that were positively correlated with UCP1 reporter activity (Fig. 4) . Two members of the integrin family, ITGA10 (encoding integrin α10) (P < 0.001) and ITGB1 (also known as CD29, which encodes integrin β1) (P < 0.001), exhibited significantly positive correlations with UCP1 levels (Fig. 6a,b) . Integrins are heterodimeric transmembrane receptors that mediate various biological functions, such as cell proliferation, differentiation, and migration 40, 41 . Using FACS with an antibody specific to CD29, we were able to separate subpopulations of cells from pooled hWAT-SVF and pooled hBAT-SVF cells on the basis of npg the abundance of CD29 on the cell surface. We noted that the hWAT-SVF population contained 22.2% CD29 low , 68.5% CD29 med and 9.3% CD29 high cells, whereas the hBAT-SVF population had almost equal proportions of CD29 med and CD29 high cells (50.2% and 49.7%, respectively) and very few CD29 low cells (0.01%) (Fig. 6c) . The ability of CD29 + hWAT-SVF cells to differentiate into lipid-laden cells appeared to positively correlate with CD29 levels (Fig. 6d) . Notably, CD29 high hBAT-SVF cells effectively differentiated into brown adipocytes that expressed the highest levels of UCP1 among all the groups (Fig. 6e,f) . These data suggested the exciting potential of using an antibody against CD29 to prospectively isolate human adipose progenitors that could give rise to mature adipocytes with great thermogenic capability.
DISCUSSION
In this study we generated cell lines that served as models to tease apart the heterogeneity of human BAT and WAT; this will, in turn, allow further investigations into the functions of these types of cells. The cell lines we generated robustly differentiated into cells and tissue that recapitulated the gene expression signature and metabolic capacity of BAT. Interestingly, differentiated hBAs displayed greater ability in glucose and fatty acid uptake, and fatty acid oxidation, compared to differentiated hWAs, indicating that human brown adipocytes are capable of using both glucose and fatty acids as fuels. In addition,
we have generated cell lines stably expressing a UCP1 reporter construct. By allowing the longitudinal measurement of UCP1 reporter activity, these cells offer great opportunities for high-throughput screens aimed at identifying targets that enhance thermogenic differentiation or activate mature cells. Furthermore, the UCP1 reporter allows for the generation of human xenograft models wherein human BAT and WAT can be dynamically assayed for induction of UCP1 in vivo. Our proof-of-concept experiment using BMP7 pretreatment of hBAT preadipocytes demonstrates the exciting prospect of using mice with human-derived BAT and WAT to screen for novel activators of thermogenesis in an in vivo setting. Microarray analysis in adipose clones revealed two general classifications of genes that regulate thermogenic differentiation: the binary 'on-and-off ' category and the continuous category. These two categories of genes suggest a distinct commitment step in brown adipogenesis, which is followed by differentiation. Both categories of genes present interesting opportunities for modulating cellular energy balance. By activating 'on' switches and deactivating 'off ' switches, it may be possible to activate pools of precursor cells to differentiate (shown as log 2 levels on the x axis) on day 0 and UCP1 mRNA levels (shown as log 2 levels on the y axis) on day 18 in ten independent hWAT-SVF and hBAT-SVF clones, as described in Figure 5a . npg into brown adipocytes. This approach may need to be combined with a second strategy targeting the genes that act as genetic rheostats with the goal of fine-tuning the regulators to increase UCP1 expression in adipocytes. Indeed, by using CRISPR-Cas9 to knock out the positive UCP1 regulators PREX1 and EDNRB in brown preadipocytes, we could almost completely abolish the high levels of UCP1 in mature brown fat cells. However, ablation of the negative regulator SSTR1 in white fat precursors failed to turn on the thermogenic program. These findings suggest that these positive regulators have an essential role in determining thermogenic competency in brown preadipocytes. By contrast, it may take a combined approach to remove multiple negative regulators-and perhaps turn on positive modulators-in the human white preadipocytes in order to activate their thermogenic program.
PREX1 is a guanine-nucleotide exchange factor for the Rho small GTP-binding proteins. It has been shown to promote glucose transporter type 4 (Glut4) trafficking in 3T3-L1 adipocytes 42 , and singlenucleotide polymorphisms near PREX1 are linked to susceptibility to type 2 diabetes through PREX1's potential effect on adiposity 43 . Endothelin, the ligand of EDNRB, can modulate intracellular calcium and cAMP levels, stimulate glucose uptake and activate lipolysis in adipocytes 44, 45 . Thus, it is possible that PREX1 and EDNRB might regulate pathways controlling fuel use in preadipocytes, which poise the cells to become thermogenically competent in mature adipocytes. The role of these markers in human obesity warrants future investigation.
Recently, Shinoda et al. 46 identified two human BAT markers, KCNK3 and MTUS1. Of note, although the expression of these genes in our preadipocyte clones does not show significant correlation with UCP1 expression in adipocytes (Supplementary Table 3) , they are indeed more highly expressed in the differentiated hBAs than in hWAs (Supplementary Fig. 9e ). Given the differences in the anatomical locations from which these cells are derived and the approaches used in these two studies, it is conceivable that distinct markers would be identified. Additionally, these findings actually complement each other because the markers identified by Shinoda et al. 46 serve as mature hBAT markers, whereas gene signatures identified in the current study represent markers in human preadipocytes that are predictive of thermogenic capacity in mature adipocytes.
Single-cell clonal analysis revealed a large number of clones that could differentiate and accurately recapitulate BAT and WAT behavior. Notably, although these cells represented a broad range of thermogenic competencies, they demonstrated a consistent increase in thermogenic capacity in BAT cells compared to WAT cells. However, the influence of each subject's characteristics was still apparent. These characteristics included genetic background, sex, and body mass index, as well as the anatomic locations from which the fat depots were collected. These factors may contribute to the differential responses to stimuli that cause preadipocytes to become thermogenically active cells upon stimulation, and this needs to be further investigated by generating and characterizing adipose precursors from additional individuals of representative populations.
Here we have shown the utility of a CD29-specific antibody to prospectively isolate human preadipocytes with high thermogenic potential, and we suggest the prospect of using this approach to assess the thermogenic potential of different patient populations. CD29 + cells from adipose tissue possess great adipogenic differentiation potential 47 . Our data also showed a similar result wherein the degree of lipid accumulation positively correlated with the levels of CD29 in hWAT-SVF cells. CD29 is involved in the formation of the transmembrane linkage between the extracellular matrix and the microfilaments 48, 49 , suggesting that the regulatory events that affect cell adhesion and cell shape during adipocyte differentiation might have a role in determining thermogenic potential.
An understanding of the cellular identity of human adipose tissue is key to formulating therapeutic interventions to treat obesity and its sequelae. The cell-based models reported here not only provide a promising opportunity to study adipogenesis and the gene patterns that regulate thermogenic competency, but also offer potential avenues for developing effective therapies for treating obesity and its many associated metabolic diseases.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Gene Expression Omnibus (GEO) repository: microarray data have been deposited with accession number GSE68544. Human subjects. This study followed the institutional guidelines of and was approved by the Human Studies Institutional Review Boards of Beth Israel Deaconess Medical Center and Joslin Diabetes Center. Details on procedures of human subject collection were described previously 20 . There were two independent human subject cohorts: for isolation and immortalization of fat progenitors, human neck fat from four subjects was analyzed (clinical characteristics of subjects are provided in Supplementary Table 1a) ; for gene expression verification, neck fat from seven different people was studied (clinical characteristics of subjects are provided in Supplementary Table 1b ). All subjects gave written informed consent before taking part in the study.
Isolation and culture of primary human white and brown fat progenitors. Isolation of primary SVF from human neck fat was described previously 20 . Owing to the limited amount of human brown fat tissue collected from surgeries, we pooled fat depots from the same subject to obtain sufficient numbers of SVF cells for primary culture as well as immortalization. Specifically, subcutaneous and subplatysmal neck fat depots were pooled to generate hWAT-SVF cells and deep neck fat depots collected from the carotid sheath, longus colli muscle and prevertebral regions were combined for generation of hBAT-SVF cells. Freshly resected fat depots were collected, minced and digested using collagenase 1 (2 mg/ml in PBS with the addition of 3.5% BSA; Worthington Biochemical Corporation, Lakewood, NJ), and the SVF was isolated. SVF cells were plated and grown in high-glucose Dulbecco's modified Eagle's medium (DMEM/H) supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillinstreptomycin. For adipocyte differentiation, cells were grown to confluence for 6 d (referred to as 'day 6') and then exposed to adipogenic induction mixture in DMEM/H medium containing 0.5 mM isobutylmethylxanthine, 0.1 µM dexamethasone, 0.5 µM human insulin (Sigma-Aldrich, Dallas, TX), 2 nM T3, 30 µM indomethacin, 17 µM pantothenate, 33 µM biotin and 2% FBS for another 12 d (referred to as 'day 18'). Induction medium was changed every 3 d until cells were collected.
Generation of immortalized human brown and white fat progenitors. Primary SVF cells were immortalized with hTERT as described 27 . Primary SVF isolated from four subjects that had undergone four or five population doublings were separately infected with a retrovirus containing the plasmid, pBABE-hTERTHygro (Addgene no. 1773, Cambridge, MA), which expresses hTERT driven by a long-terminal-repeat promoter. Phoenix-A cells (ATCC) were transfected with pBABE-hTERT-Hygro DNA using PolyJet DNA in vitro transfection reagent (SignaGen Laboratories, Rockville, MD). Culture supernatants containing virus were collected every 24 h after transfection and filtered through a 0.45 µm filter (Fisher Scientific, Pittsburgh, PA). Primary SVF cells from human white and brown fat at 80% confluence were infected with supernatants in the presence of 4 µg/ml Polybrene every day until cells reached 90% confluence. Cells were then treated with hygromycin (concentrations ranging from 100 µg/ml to 400 µg/ml, depending on cell conditions) in DMEM/H medium containing 10% FBS and antibiotics. Once drug selection was finished, the cells were maintained in culture medium with 50 µg/ml hygromycin for 2 weeks.
Culture and differentiation of immortalized human white and brown fat progenitors. Immortalized progenitor cells were plated and grown in DMEM/H medium supplemented with 10% FBS (day 0). For adipocyte differentiation, cell were grown for 6 d until reaching confluence (day 6), and then treated with the adipogenic induction medium as described above for 12 d (day 18). To further stimulate the thermogenic program, fully differentiated cells were incubated with 10 µM forskolin or 1 µM norepinephrine for 4 h. For BMPs and FGF21 pretreatment, recombinant BMP7 (3.3 nM), BMP8 (3.3 nM) or FGF21 (50 nM) were added to undifferentiated cells in medium containing insulin (0.5 µM), T3 (2 nM) and 2% FBS for 6 d followed by adipogenic induction for 12 d. For BMPs and FGF21 post-treatment, fully differentiated adipocytes at day 18 were treated with recombinant BMP7 (3.3 nM), BMP8 (3.3 nM) or FGF21 (50 nM) in medium containing insulin (0.5 µM), T3 (2 nM) and 2% FBS for 2 d. We routinely checked for mycoplasma contamination and all the cells used in this study were free of mycoplasma.
Oil Red O staining. Cells were washed twice with PBS and fixed with 10% buffered formalin for 30 min at room temperature. Cells were then stained for 4 h at room temperature with a filtered Oil Red O solution (0.5% Oil Red O in isopropyl alcohol), washed twice with distilled water, and then visualized.
Quantitative RT-PCR. RNA extraction, cDNA synthesis, and qRT-PCR were performed as described before 20, 29 . qRT-PCR assays were run in duplicate and quantified in the ABI Prism 7900 sequence-detection system using SYBR (Roche Applied Science, Indianapolis, IN). Relative mRNA expression was determined by the ∆C t method and the values were normalized to the expression of 18S ribosomal RNA (18S). The sequences of primers used in this study are provided in Supplementary Table 5. Western blotting. Protein detection by western blotting was performed as described before 29 . Primary antibodies were incubated overnight at 4 °C: UCP1 (1:500, rabbit polyclonal; Abcam, Cambridge, MA) and α-tubulin (1:4,000, mouse monoclonal). HRP-coupled secondary antibodies (Cell Signaling Technologies, Beverly, MA) were used at 1:2,000 dilutions at room temperature for 2 h followed by detection using the Amersham enhanced chemiluminescence (ECL) prime (GE healthcare, Pittsburgh, PA).
Bioenergetic profiling. To assess mitochondrial respiration, a Seahorse Extracellular Flux Analyzer (Seahorse Bioscience Inc., North Billerica, MA) was used to quantify oxygen consumption rates (OCR) of differentiated human white and brown adipocytes. Progenitor cells were seeded on 24-well format plates and allowed to adhere overnight. After 6 d, adipogenesis was induced as described above. After adipogenic induction for 12 d, OCR was analyzed. To measure OCR independent of oxidative phosphorylation, 0.5 µM oligomycin (EMD Chemicals Inc., Gibbstown, NJ) was added to cells. Subsequently, 0.8 µM FCCP (carbonyl cyanide-p-trifluoromethoxyphenylhydrazone) and 1 µM respiratory chain inhibitor (rotenone) were added to measure maximal respiration and basal rates of nonmitochondrial respiration. For cAMP-induced respiration, fully differentiated adipocytes were incubated with 10 µM forskolin for 4 h. For BMP7 pretreatment-induced respiration, recombinant BMP7 (3.3 nM) was added to the undifferentiated cells for 6 d and then adipogenic induction mixture medium was added to the confluent cells for 12 d, followed by measurement of cellular respiration. All data were average of four time points with 10 wells per time point quantified in bar plots, and error bars are s.e.m. Statistical comparisons were done by Student's t-test.
Glucose uptake assay. After serum starvation in DMEM/H medium containing 1% BSA for 2-3 h, differentiated human white and brown adipocytes were washed with HEPES buffer. Then they were incubated with or without 100 nM insulin for 30 min in DMEM/H medium containing 1% BSA. Glucose transport was determined by the addition of 2-deoxy-[ 3 H]glucose (0.1 mM, 0.5 µCi/ml; PerkinElmer Life and Analytical Science, Waltham, MA). After 5 min of incubation, the reaction was stopped with ice-cold PBS and cells were washed twice in ice-cold PBS. Cells were then lysed in 0.1% SDS, and glucose uptake was assessed in 4 ml of scintillant using a Beckman LS6500 scintillation counter (Beckman Coulter, Indianapolis, IN). Nonspecific 2-deoxy-[ 3 H]glucose uptake was measured in the presence of cytochalasin B (20 µM) and was subtracted from the total uptake to get specific glucose uptake. Results were expressed as the mean ± s.e.m. of the indicated number of experiments. The protein content was determined by the Bradford method.
Fatty acid uptake and fatty acid oxidation assays. Fatty acid uptake and oxidation were determined by measuring both [ 14 C]palmitic acid uptake and npg conversion of [ 14 C]palmitic acid into CO 2 . Briefly, the culture medium was removed, and cells were incubated with DMEM/H containing 4% fatty acid-free BSA, 0.5 mM palmitic acid, and 0.2 µCi/ml [1-14 C]palmitic acid (PerkinElmer Life and Analytical Science, Waltham, MA) for 1 h. The incubation medium was transferred to a vial containing 1 M acetic acid, capped quickly, and allowed to sit for 1 h for the 14 CO 2 gas to be released. 14 CO 2 released was absorbed by hyamine hydroxide, and activity was counted. Fatty acid oxidation was calculated from 14 CO 2 generated. To measure fatty acid uptake, cells were rinsed twice with PBS and lysed after incubation with [1-14 C]palmitic acid. Lipids were extracted using a chloroform-methanol mixture (2:1), and 14 C counts were determined in the organic phase. Fatty acid uptake was calculated as the total of 14 C lipids in the cells and 14 CO 2 generated.
Generation of cells with a hUCP1 reporter system. Immortalized human fat progenitor cells were infected with a lentivirus containing the plasmid, pLV.ExBi. P/Puro-hUCP1promoter-Luc(firefly)-T2A-hrGFP, which expresses luciferase and GFP driven by the human UCP1 promoter. The 4,148-bp human UCP1 promoter was cloned from pLightSwitch_hUCP1-Prom (S723122; Switch Gear Genomics, Carlsbad, CA) and was then subcloned into a lentiviral plasmid to generate a plasmid containing a UCP1 reporter system (Cyagen Biosciences Inc., Santa Clara, CA). 293T cells (ATCC) were transfected with hUCP1promoter-Luc-T2A-GFP, pMD2.G and psPAX2 DNA using PolyJet DNA in vitro transfection reagent (SignaGen Laboratories, Rockville, MD). Culture supernatants containing virus were collected every 24 h after infection and filtered through a 0.45 µm filter (Fisher Scientific, Pittsburgh, PA). Immortalized human white and brown fat progenitors at 80% confluence were infected with viral supernatants in the presence of 4 µg/ml Polybrene every day until cells reached 90% confluence. Then cells were treated with 1 µg/ml puromycin in DMEM/H medium containing 10% FBS and antibiotics. Once drug selection was finished, the cells were maintained in culture medium with 0.2 µg/ml puromycin for 2 weeks.
Luciferase reporter assay. In vitro luciferase assays were performed using luciferase assay kits (Promega, Madison, WI) according to the manufacturer's instructions. Culture medium from differentiated adipocytes was removed and the cells washed in PBS. An appropriate volume of 1× lysis reagent (passive lysis buffer) was dispensed into each culture well. Cells were scraped from the wells and the lysates transferred into white 96-well plates (Corning Inc., Tewksbury, MA) for detection of the bioluminescence signal using a luminometer plate reader (BioTek Instruments, Inc., Winooski, VT). Reagent injectors were used to dispense 100 µl of luciferase assay buffer with substrate and 100 µl of Stop & Glo reagent. We used a 2-s premeasurement delay followed by a 10-s measurement period for each reporter assay. Luciferase activity data were normalized to protein content.
Time-lapse imaging. Human immortalized cells with hUCP1-promoter-Luc/ GFP were plated on a Hi-Q4 culture dish (Nikon, Tokyo, Japan) and cultured in a Nikon BioStation IM-Q (Nikon, Tokyo, Japan), which is a compact cell incubator and monitoring system that allows for live-cell imaging. Cells were maintained in BioStation IM-Q at 37 °C in a 5% CO 2 environment. Adipogenesis was induced as described. Bright-field and fluorescence images were obtained every hour over the course of every 3 d between medium changes for a total of 18 d.
Cell transplantations and in vivo luciferase imaging. Human immortalized white and brown fat progenitors with hUCP1-promoter-Luc/GFP were grown in the presence or absence of 3.3 nM BMP7 for 6 d to reach confluence. Cells were washed, trypsinized and resuspended in growth medium with an equal amount of Matrigel Matrix (BD Biosciences, San Diego, CA). Then 1.0 × 10 7 cells in a 0.3-ml volume were injected into the thoracic-sternum region of 6-week-old male BALB/c athymic nude mice (n = 2 mice for white fat progenitors transplantation group, n = 3 mice for brown fat progenitors transplantation group; Harlan laboratories, Indianapolis, IN) using an 18-gauge needle, according to the methods described previously 23, 29 . No statistical method was used to predetermine sample size and experiments were not randomized. For acquisition of the bioluminescence images, the mice were sedated with 2% isoflurane in 100% O 2 in the chamber. D-Luciferin (PerkinElmer Life and Analytical Science, Waltham, MA) was diluted to 3 mg/100 µl in normal saline and 0.6 mg of D-Luciferin was administrated intraperitoneally into mice. An IVIS-Spectrum CT imaging system equipped with a CCD camera (Caliper, PerkinElmer Life and Analytical Science, Hopkinton, MA) was used for in vivo bioluminescence imaging. The luminescence intensity in regions of interest from each image was quantified to examine the viability of the implanted cells. Mice were scanned by IVIS each week after transplantation. After 6 weeks of transplantation, mice were sacrificed, and adipose tissue derived from implanted cells was excised and processed for qRT-PCR analysis. There was no blinding during animal experiments. The animal experiment was performed according to procedures approved by the Joslin Diabetes Center Institutional Animal Care and Use Committee (IACUC).
